Chemicals & Advanced Materials Global On demand · 24-48h

Global Pharma Tablet Coating Systems Market Strategic Research Report

Global Pharma Tablet Coating Systems Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Pharma Tablet Coating Systems Market
$5062025
6.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Laboratory Coating System, Pilot Coating System, Production Batch Coating System, Continuous Coating System, Others

By Application: Pharmaceutical Manufacturing, Academic and Research Institutes, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Freund Corporation, IMA Group, GEA Group, Syntegon Technology, L.B. Bohle, Glatt Group, ACG Engineering, Fluid Air Inc., Nicomac, NEOMACHINE MFG Co., Solace Engineers, Yenchen Machinery, Prism Pharma Machinery, INORA Pharmaceutical Machinery, O’Hara Technologies, DIOSNA Dierks & Söhne, Jinlu Packaging, Wonsen Machinery, SED Pharma, Iven Pharmatech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 145 pages
Market size 2025
$506
Million USD
Forecast CAGR
6.8%
2025-2032
Forecast 2032
$802
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Pharma Tablet Coating Systems market size is predicted to grow from US$ 506 million in 2025 to US$ 811 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.

In 2025, global Pharma Tablet Coating Systems production reached approximately 1,150 units, with an average global market price of around 450,000 US$/unit.

Pharma Tablet Coating Systems are specialized pharmaceutical manufacturing equipment used to apply uniform coating layers onto tablets, pellets, granules, or other solid dosage forms under controlled GMP conditions. These systems typically include perforated coating pans, spray guns, air handling units, exhaust and filtration systems, solution preparation units, control systems, and optional containment or cleaning-in-place functions. They are used for film coating, sugar coating, enteric coating, moisture protection, taste masking, color identification, controlled release, and product stability improvement. Compared with simple coating pans, modern pharma tablet coating systems emphasize coating uniformity, batch reproducibility, solvent safety, process automation, temperature and humidity control, cleaning validation, and compliance with pharmaceutical production standards.

Demand for Pharma Tablet Coating Systems is mainly driven by the expansion of solid oral dosage manufacturing, generic drug production, high-potency drug development, controlled-release formulations, and stricter requirements for product appearance, stability, and patient compliance. Pharmaceutical companies increasingly need automated, closed, energy-efficient, and validation-friendly coating systems that can reduce coating defects, shorten batch changeover time, improve yield, and support multiple coating recipes. Business opportunities are strong in production-scale perforated pan coaters, R&D and pilot-scale systems for formulation development, high-containment coating equipment for potent APIs, and continuous coating systems for advanced manufacturing. Emerging markets also create opportunities for cost-effective GMP coating machines, while developed markets favor systems with data integrity, process analytical technology, recipe control, solvent recovery, and integrated cleaning functions.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharma Tablet Coating Systems market?

What factors are driving Pharma Tablet Coating Systems market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharma Tablet Coating Systems market opportunities vary by end market size?

How does Pharma Tablet Coating Systems break out by System Configuration, by Application?

This report presents a comprehensive overview of the global Pharma Tablet Coating Systems market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by System Configuration

  • Laboratory Coating System
  • Pilot Coating System
  • Production Batch Coating System
  • Continuous Coating System
  • Others

Segment by Coating Technology

  • Perforated Pan Coating System
  • Conventional Pan Coating System
  • Fluid Bed Coating System
  • High-Containment Coating System
  • Others

Segment by Batch Capacity

  • Micro Batch System: Below 5 Kg Per Batch
  • Small Batch System: 5–30 Kg Per Batch
  • Medium Batch System: 31–150 Kg Per Batch
  • Large Batch System: 151–500 Kg Per Batch
  • Ultra-Large Batch System: Above 500 Kg Per Batch

Segment by Application

  • Pharmaceutical Manufacturing
  • Academic and Research Institutes
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pharma Tablet Coating Systems market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceutical Manufacturing, Academic and Research Institutes, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Pharma Tablet Coating Systems Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$506
2025
Forecast
$802
2032
CAGR
6.8%
2025–2032
Regions
5
global
Key companies
Freund CorporationIMA GroupGEA GroupSyntegon TechnologyL.B. BohleGlatt GroupACG EngineeringFluid Air Inc.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Laboratory Coating SystemPilot Coating SystemProduction Batch Coating SystemContinuous Coating SystemOthers
By Application
Pharmaceutical ManufacturingAcademic and Research InstitutesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Laboratory Coating System
  • 3.1.3 Pilot Coating System
  • 3.1.4 Production Batch Coating System
  • 3.1.5 Continuous Coating System
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceutical Manufacturing
  • 4.1.3 Academic and Research Institutes
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Freund Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 IMA Group
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 GEA Group
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Syntegon Technology
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 L.B. Bohle
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Glatt Group
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 ACG Engineering
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Fluid Air Inc.
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Nicomac
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 NEOMACHINE MFG Co.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Solace Engineers
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Yenchen Machinery
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Prism Pharma Machinery
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 INORA Pharmaceutical Machinery
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 O’Hara Technologies
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 DIOSNA Dierks & Söhne
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Jinlu Packaging
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Wonsen Machinery
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 SED Pharma
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Iven Pharmatech
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Pharma Tablet Coating Systems market?
The global Pharma Tablet Coating Systems market is estimated at US$ 506 million in 2025 (base year) and is projected to reach US$ 811 million by 2032.
What is the forecast CAGR for the Pharma Tablet Coating Systems market?
The market is expected to grow at a CAGR of 6.8% from 2026 to 2032, expanding from US$ 506 million in 2025 to US$ 811 million in 2032, roughly 1.6 times its base-year value.
What is Pharma Tablet Coating Systems?
In 2025, global Pharma Tablet Coating Systems production reached approximately 1,150 units, with an average global market price of around 450,000 US$/unit.
How is the Pharma Tablet Coating Systems market segmented by system configuration?
By system configuration, the market is segmented into Laboratory Coating System, Pilot Coating System, Production Batch Coating System, Continuous Coating System and Others.
What are the key applications of Pharma Tablet Coating Systems?
Key applications covered include Pharmaceutical Manufacturing, Academic and Research Institutes and Others.
Which companies are profiled in the Pharma Tablet Coating Systems market report?
Key players profiled include Freund Corporation, IMA Group, GEA Group, Syntegon Technology, L.B. Bohle, Glatt Group, ACG Engineering and Fluid Air Inc., among 20 companies covered in total.
What geographies does the Pharma Tablet Coating Systems market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Pharma Tablet Coating Systems?
Demand for Pharma Tablet Coating Systems is mainly driven by the expansion of solid oral dosage manufacturing, generic drug production, high-potency drug development, controlled-release formulations, and stricter requirements for product appearance, stability, and patient compliance.
Who should buy the Pharma Tablet Coating Systems market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical Manufacturing, Academic and Research Institutes and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Pharma Tablet Coating Systems market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.